Indoco Remedies Limited (NSE:INDOCO)
India · Delayed Price · Currency is INR 173.46
-12.44 (-6.69%)
At close: Mar 27, 2026
Indoco Remedies Market Cap
Indoco Remedies has a market cap or net worth of 16.01 billion as of March 27, 2026. Its market cap has decreased by -25.34% in one year.
Market Cap
16.01B
Enterprise Value
25.75B
Revenue
17.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
173.46
Market Cap Chart
Since January 14, 2005, Indoco Remedies's market cap has increased from 4.66B to 16.01B, an increase of 243.58%. That is a compound annual growth rate of 5.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 16.01B | -26.02% |
| Dec 31, 2025 | 21.64B | -29.33% |
| Dec 31, 2024 | 30.62B | -15.91% |
| Dec 29, 2023 | 36.42B | -2.82% |
| Dec 30, 2022 | 37.47B | -10.49% |
| Dec 31, 2021 | 41.86B | 49.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 39.23B |
| Innova Captab | 38.42B |
| RPG Life Sciences | 30.84B |
| Orchid Pharma | 25.48B |
| Solara Active Pharma Sciences | 21.33B |
| Windlas Biotech | 16.12B |
| Jagsonpal Pharmaceuticals | 12.37B |
| Ind-Swift Laboratories | 11.98B |